The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans. by Bouché, Laura et al.
Bouch, L; Panico, M; Hitchen, P; Binet, D; Sastre, F; Faulds-Pain,
A; Valiente, E; Vinogradov, E; Aubry, A; Fulton, K; Twine, S; Lo-
gan, SM; Wren, BW; Dell, A; Morris, HR (2016) The Type B Flag-
ellin of Hypervirulent Clostridium difficile is Modified with Novel
Sulphonated Peptidylamido-Glycans. The Journal of biological chem-
istry, 291 (49). pp. 25439-25449. ISSN 0021-9258 DOI: https://doi.org/10.1074/jbc.M116.749481
Downloaded from: http://researchonline.lshtm.ac.uk/2997172/
DOI: 10.1074/jbc.M116.749481
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
The Type B Flagellin of Hypervirulent Clostridium difficile Is
Modified with Novel Sulfonated Peptidylamido-glycans*
Received for publication, July 20, 2016, and in revised form, September 12, 2016 Published, JBC Papers in Press,October 7, 2016, DOI 10.1074/jbc.M116.749481
Laura Bouché‡, Maria Panico‡, Paul Hitchen‡, Daniel Binet§, Federico Sastre‡1, Alexandra Faulds-Pain¶,
Esmeralda Valiente¶2, Evgeny Vinogradov, Annie Aubry, Kelly Fulton, Susan Twine, Susan M. Logan,
BrendanW. Wren¶, X Anne Dell‡3, and Howard R. Morris‡§
From the ‡Department of Life Sciences, Imperial College London, South Kensington Campus, London SW7 2AZ, United Kingdom,
the ¶Department of PathogenMolecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, LondonWC1E
7HT, United Kingdom, the Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, Ottawa, Ontario
K1A 0R6, Canada, and §BioPharmaSpec, Suite 3.1 LidoMedical Centre, St. Saviours Road, Jersey JE2 7LA, United Kingdom
Edited by Dennis Voelker
Glycosylation of flagellins is a well recognized property of
many bacterial species. In this study, we describe the structural
characterization of novel flagellar glycans from a number of
hypervirulent strains ofC. difficile. We usedmass spectrometry
(nano-LC-MS and MS/MS analysis) to identify a number of
putative glycopeptides that carried a variety of glycoform sub-
stitutions, each of which was linked through an initialN-acetyl-
hexosamine residue to Ser or Thr. Detailed analysis of a LLDG-
SSTEIR glycopeptide released by tryptic digestion, which
carried two variant structures, revealed that the glycopeptide
contained, in addition to carbohydrate moieties, a novel struc-
tural entity. A variety of electrospray-MS strategies using
Q-TOF technology were used to define this entity, including
positive and negative ion collisionally activated decomposition
MS/MS, which produced unique fragmentation patterns, and
high resolution accurate mass measurement to allow derivation
of atomic compositions, leading to the suggestion of a taurine-
containing peptidylamido-glycan structure. Finally, NMR anal-
ysis of flagellin glycopeptides provided complementary infor-
mation. The glycan portion of the modification was assigned as
-Fuc3N-(133)--Rha-(132)--Rha3OMe-(133)--GlcNAc-
(13)Ser, and the novel capping moiety was shown to be com-
prised of taurine, alanine, and glycine. This is the first report of
a novel O-linked sulfonated peptidylamido-glycan moiety dec-
orating a flagellin protein.
The intestinal pathogen Clostridium difficile is the leading
cause of antibiotic-associated diarrhea worldwide. The patho-
gen colonizes the gastro-intestinal tract when the normal
microbiota is disturbed after antibiotic treatment, causing
C. difficile infection in susceptible patients. In the past decade,
C. difficile infection mortality has increased dramatically since
the emergence of hypervirulent strains, such as the PCR
ribotype 027 (RT027)4 and RT023 lineages (1, 2).
The reasons for the increase in severity of C. difficile infec-
tion caused by hypervirulent strains are still not well under-
stood. Molecules implicated in C. difficile virulence include
the secreted toxins TcdA and TcdB and a variety of cell sur-
face biopolymers (3–6). Among the latter, flagella, which are
responsible for the pathogen’s motility, are believed to have
roles in virulence because disruption of their biosynthesis and
expression affects colonization, biofilm formation, and toxin
production (7).
The flagellin proteins of C. difficile are known to be post-
translationallymodified withO-linked glycans, and there is evi-
dence that glycosylation can affect motility and virulence (8, 9).
Flagellin O-glycosylation is widespread in Gram-negative bac-
teria (10) but so far has only been found in three Gram-positive
genera, Clostridium, Listeria, and Paenibacillus (11–13). A
great deal of diversity exists among flagellin glycans, but there
are some common themes. For instance, many Gram-negative
flagellins have a single pseudaminic acid or legionaminic acid
residue at each of their O-glycosylation sites. These sugars can
be substituted with a variety of functionalities, such as acyl and
acetamido groups, resulting in considerable structural hetero-
geneity. Interestingly, the first Clostridium species to have its
flagellin glycosylation characterized, Clostridium botulinum,
was found to share this type of glycosylation. Thus, its flagellin
is substituted with the legionaminic acid derivative 7-acet-
amido-5-(N-methyl-glutam-4-yl)-amino-3,5,7,9-tetradeoxy-
D-glycero--D-galacto-nonulosonic acid (Leg5GluNMe7Ac)
(12) In contrast, C. difficile post-translational modifications
appear to be quite different in structural composition from
those that have been found in Gram-negative organisms.
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The best characterized C. difficile flagellin is that from the
first strain to have its genome sequenced (14). This PCR
ribotype 012 strain (strain 630) was isolated from a Swiss hos-
pital patient in 1982. It is an epidemic, multidrug-resistant
strain and predates the emergence of the hypervirulent strains.
The 630 flagellin is modified at up to seven sites with the mon-
osaccharide N-acetylglucosamine (GlcNAc), which is substi-
tuted with a phosphodiester-linked N-methyl-L-threonine res-
idue (8, 9). RT027 and RT023 strains, however, appear to lack
this unusual amino acid modification. Preliminary data from
MS investigations of RT027 flagellins were interpreted as con-
sistent with the presence of HexNAc-linked oligosaccharides
up to a pentasaccharide in length. Mass increments in the MS
data were attributed to various compositions of deoxyhexose,
methylated deoxyhexose, HexNAc, and heptose, but full struc-
tures were not defined at that time because of technological
limitations (8).
In this study, we have rigorously characterized flagellin gly-
cosylation in several emerging hypervirulent clonal strains,
including RT027, RT023, RT106, and RT001. We have discov-
ered several variants of a novel peptidylamido-glycan sulfonate
structure decorating hydroxyamino acids (Ser and Thr) in the
flagellin (FliC) protein. Here we describe the chemical charac-
terization of this newly discovered structure using Q-TOF
technology (15, 16) applied in a variety of structural elucida-
tion strategies (17, 18), including positive and negative ion
collisionally activated decomposition (CAD) MS/MS to pro-
duce unique and interpretable fragmentation patterns and
high resolution accurate mass measurement to allow deriva-
tion of detailed atomic compositions. Confirmation and
extension of the MS structural interpretations was then
made by purifying a number of glycopeptides in sufficient
quantities to define each structure by NMR.
Results
Mass Spectrometric Analysis of Flagellin Glycopeptides—A
preliminary structure of RT027 flagellin glycosylation had been
studied previously by LC-MS/MS analysis (8), but full struc-
tures were not solved due to technical limitations. In the study
presented here, following nano-LC-MS and MS/MS analysis, a
number of putative glycopeptides derived from RT0207 and
other flagellins were identified via a search for oxonium ions
(e.g. m/z 204) in the data sets. This led to the discovery of a
number of glycopeptide candidates carrying a variety of glyco-
form substitutions, including the peptides LLDGSSTEIR,
VALVNTSSIMSK, and QMVSSLDVALK. Each of these pep-
tides carried a glycan modification that was linked through an
initial HexNAc residue to Ser or Thr, followed by deoxyHex/
methyldeoxyHex, methyldeoxyHex/deoxyHex, and methylde-
oxyHex/methyldeoxyHex in positions 2/3, respectively. The
majority of structural work reported here has concentrated on
the LLDGSSTEIR glycopeptides from strain R20291, and inter-
estingly, two variant structures carried on this peptide were
present in the LC-MS chromatograms atm/z 9982 and 9912,
where the MS/MS fragmentation pattern clearly showed (in
addition to carbohydrate moieties) the presence of a novel
structural entity not previously observed in sugar or amino acid
chemistry.
TheCADMS/MS spectra ofm/z 9982 and 9912molecules
are shown in Fig. 1, with the main spectrum showing the high
resolution data (to 4 decimal places) for the larger molecule
(m/z 9982), and the inset showing the low resolution spectrum
ofm/z 9912 for comparison. From these data, it is clear that a
HexNAc-methyldeoxyHex-deoxyHex- glycosyl substituent is
attached to the peptide backbone (seen at 1090, MH) via
signals at m/z 1293, 1453, and 1599, respectively (correspond-
ing to glycosidic cleavages), together with a series of y ions
beginning atm/z 749 and extendingwith the same substituents,
identically for both precursor ions. A further less intense signal
is present atm/z 1744 in the high resolution data extending the
glycosylation sequence by an amino-dideoxyHex unit. The high
resolution mass measurement of the 9912 signal compared
with the 9982 signal shows that the 14-atomic mass unit mass
difference corresponds to a CH2 difference between the two
structures. The clearly novel aspect of these glycopeptides can
be seen in the substantial fragment ions at m/z 396, 378, 268,
251, 223, and 152, which do not immediately correlate with
sugar or amino acid origin. The equivalent signals are present in
the 9912 data (inset spectrum) 14 Da lower at m/z 382, 364,
254, 237, 209 except form/z 152 (same), showing that the 14-Da
mass difference resides between the 152 and 396/382 fragments
in the structure. When cross-correlating the observed 396/382
and 1599 signals with the molecular masses observed in the
9982/9912 quasimolecular ions, these fragments are additive
to the molecular mass (allowing for hydrogen transfers) and
thus represent between them the overall glycopeptide struc-
ture, as shown schematically in Fig. 1 for the 9982 variant.
The interpretation of the mechanisms leading to these frag-
ment ions was greatly assisted by the atomic compositions
determined from the accurate masses in the high resolution
Q-TOF data (see representative data in Table 1) and also by the
presence of “counterion” data, as is often observed in doubly
charged MS/MS spectra. For example, the aminodideoxyHex
residue extension from m/z 1599 to 1744 must therefore be
present in them/z 396 counterpart, and its partial loss (128 Da)
by -elimination is observed to givem/z 268 in Fig. 1, whereby
the amino function is retained by the 268 ion, which itself then
loses first ammonia to m/z 251 and then carbon monoxide to
m/z 223 from the amide group thus assigned. The charge can of
course be retained for a proportion of fragments on the “coun-
terion” instead ofm/z 268, which would be present atm/z 129
from the elimination mechanism. The significant signal atm/z
111 (C6H7O2) was assigned to that origin via loss of water to
give a highly stable triply conjugated cyclic ion, available with-
out rearrangement by postulating a 3-amino substitution. The
next significant ion in the low mass region is seen at m/z 152,
and it was recognized that the observed accurate mass differ-
ence of 71.037 Da (223.0753 minus 152.0383), could corre-
spond to either an alanine or its isomer N-methyl glycine
(atomic composition C3H5NO, theoretical mass 71.0371). In
mechanistic terms, the carbonyl of such a unit could be forming
the amide linkage to the amino sugar inm/z 396, which would
predictably fragment to give the 268, 251 (b2), and 223 (a2) ions
and then to give a terminal “b1” ion atm/z 180 (from loss of Ala
or N(Me)Gly), the signal for which is not observed. However,
them/z 152 mass is 28 daltons (CO from the atomic compo-
C. difficile Type B Flagellin Glycosylation
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sition) below this mass, and it is very common for the a1 ion
subfragment (an aldimine) to be the more intense ion in
peptide fragmentation, particularly if the nitrogen is alky-
lated by methyl or another grouping giving rise to a tertiary
nitrogen. The summary of the interpretation logic used to
assign the above MS signals at that stage of the study is
shown in Scheme 1.
Them/z 152 signal was found to possess an unusually mass-
deficient accurate mass, which suggested a sulfur-containing
atomic composition determined as C4H10NO3S for this termi-
nal fragment, which is not the formula of any previously
reported protein- or carbohydrate-derived structural unit. To
help define this fragment inmore detail and to provide support-
ing evidence for the ideas in Scheme 1, two further sets of
experimentswere carried out on the remaining small quantities
of material: (a) MS/MS analysis of several of the key fragment
ions above to confirm mechanistically understandable break-
down products and (b) experiments in the negative ionMS and
MS/MS modes to look for new and complementary fragment
ion information.
CADMS/MS of the cone voltage-inducedm/z 152 from the
9912 and 9982 glycopeptide samples gives rise to two princi-
pal ion species seen in Fig. 2 atm/z 108 (C2H6NO2S) andm/z 70
(C4H8N), suggesting two overlapping component fragments
(a sulfonic acid and an alkylamine) competitively derived from
the m/z 152 ion (C4H10NO3S). The negative ion CAD MS/MS
spectrum obtained form/z 9962 is shown in Fig. 3. First, these
data confirm the basic structural features of the novel glycosyl-
ation inferred from the positive ion data in Fig. 1 and shown in
Scheme 1 regarding expected principal fragments at m/z 921,
718, 540, 394, 266, 180, and 150, with m/z 718, for example,
corresponding to X-aminodideoxyHex-deoxyHex-methylde-
oxyHex. Some other signals are derived from the carrier pep-
tide LLDGSSTEIR, but importantly, a new fragment ion (with
the equivalent not being observed in the positive ion MS/MS),
FIGURE 1. Positive ion on-line nano-LC MS/MS high resolution CAD mass spectrum of m/z 9982 (main spectrum) with equivalent low resolution
MS/MSspectrumofm/z9912 (inset).Note the lowmass signals (belowm/z400),manyofwhichdonot correlatewith either knownpeptideor carbohydrate
fragments andwhich therefore indicated the discovery of novel structural features in these glycopeptides. For full interpretation, see “Results” and Scheme 1.
TABLE 1
Atomic compositions deduced for key signals in the high resolution
MS/MS data
This table shows the deduced atomic compositions for the experimental (measured)
masses observed for key signals in the high resolutionMS/MS data (Fig. 1) together
with the theoretical masses of those compositions. Note that certain fragments,
such as peptide y ions and the peptide quasimolecular ion (MH) serve as useful
internal standards, confirming the mass accuracies across the data set. Key discov-
eries from these data included the finding of sulfur in them/z 152 and higher mass
fragments, thus confirming a novel structural unit and allowing the interpretation of
a clear fragmentation pathway between the m/z 396 and 152 ions. For a full inter-
pretation, see “Results” and Scheme 1.
Observed mass
(m/z)
Atomic composition
assigned
Theoretical mass
(m/z)
111.0441 C6H7O2 111.0446
152.0383 C4H10NO3S 152.0381
175.1192 y1 175.1195
204.0873 C8H14NO5 204.0872
223.0753 C7H15N2O4S 223.0752
251.0700 C8H15N2O5S 251.0701
268.0965 C8H18N3O5 S 268.0967
288.2034 y2 288.2035
378.1333 C14H24N3O7S 378.1335
396.1432 C14H26N3O8S 396.1441
749.3781 y7 749.3793
952.4579 Y7HexNAc 952.4587
1090.5752 Peptide (MH ) 1090.5745
1293.6548 PeptideHexNAc 1293.6538
C. difficile Type B Flagellin Glycosylation
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is seen atm/z 124, and this was recognized as corresponding to
the mass of aminoethyl-sulfonic acid, taurine (C2H6NO3S,
MH). TheMS/MS of this 9962-derived signal gave rise to
an MS/MS spectrum (Fig. 4) identical to that observed for a
synthetic sample of taurine itself, beingmainly an SO3. fragment
ion base peak, thus providing strong evidence for this structural
unit within them/z 152 ion in the novel structure.
Further experiments involving subfragmentMS/MS and also
hydrogen/deuterium exchange to count heteroatom-linked
protons were carried out to validate the structural conclusions
from the mass spectrometric experiments (data not shown),
but as seen in the structural summary in Scheme 1, an ambigu-
ity nevertheless remains in the proposed novel m/z 268 unit,
whereby although the amino acid amide-linked to the amino-
dideoxyHexwould be glycine in the 9912 structure, it could be
either alanine or N-methyl glycine in the 9982 structure.
There are also several possible ways of arranging the R, R1, and
R2 atoms in the unit incorporating the aminoethyl sulfonic
SCHEME 1. Summary of the interpretation andmechanistic logic used to assess themass spectrometric fragmentation data determined in this study
(see Fig. 1) showing the probable structural assignments. Conclusions were aided by the derivation of atomic compositions of key fragments shown in
Table 1.
C. difficile Type B Flagellin Glycosylation
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acid-containingm/z 152 (m/z 180) structure, including variants
containing taurine itself or cysteic acid with alkylations, to pro-
duce the necessary accurate masses observed, thus satisfying
the atomic compositions determined from high resolution
mass measurement. To fully characterize the R-groups in
Scheme 1 and to define the stereochemistry and linkages, a
scaled up preparation of flagellin was made, which was used to
then allow the isolation of sufficient material for the derivation
of NMR data.
NMR Analysis of Flagellin Glycopeptides—Flagellin protein
(15 mg) was extensively digested with proteinase K to enable
purification of sufficient quantities of glycanmaterial withmin-
imal peptide backbone for NMR structural analysis. This pro-
teinase K-digested material was subjected to fractionation to
obtain glycan-enriched material using size exclusion (Biogel
P10) chromatography followed by Zorbax C18 reverse phase.
All fractions were analyzed by 1H NMR to identify fractions
containing glycopeptide material. Three fractions were
obtained following chromatographic separation, which con-
tained sufficient amounts of glycopeptide for further structural
characterization. Fraction 21 from the initial Zorbax C18 col-
umn separation contained a mixture of two glycan species
(compounds 1 and 2, Fig. 5). Fraction 23 and the reseparated
fraction 12 contained compounds 2 and 3 (Fig. 5).
2D NMR spectra (COSY, TOCSY, ROESY, 1H-13C HSQC,
HMBC, andHSQC-TOCSY)were recorded for all glycopeptide
fractions. Spectra of fraction 21 (Table 2) contained spin sys-
tems of-Rha3OMe (Fig. 5,A andB),-GlcNAc (C), two serine
residues, and one threonine residue. The position of themethyl
group on Rha3OMe was determined from HMBC correlation
betweenMeandH/C-3ofthissugar.Thesequenceofthemonosac-
charides followed from NOE and HMBC correlations between
H-1 of residue B and H/C-2 of the residue A, and between H-1
of A andH/C-3 of-GlcNAcC.H-1 of GlcNAcC showedNOE
FIGURE 2.Positive ion nanospray CADMS/MS spectrumofm/z 152produced via cone voltage-induced in-source fragmentation ofm/z 9982. Signals
atm/z 70 and 108 correspond to losses of 82 and 44mass units, respectively, andwere correlatedwith the lowmass high resolution data from Fig. 1 to deduce
atomic compositions for these ions of C4H8N andC2H6NO2S. This suggests two overlapping fragments derived from them/z 152 ion (C4H10NO3S in Table 1), an
alkylamine and a possible sulfonic acid. For a full interpretation, see “Results” and Scheme 1.
FIGURE 3. Negative ion nanospray CADMS/MS spectrum ofm/z 9962 (m/z 100–1200 mass range). Negative ion fragmentation data complement and
expand those from positive ion experiments, as here form/z 394 (equivalent tom/z 396 in Fig. 1),m/z 266 (m/z 268),m/z 173 (m/z 175), andm/z 150 (m/z 152).
Interestingly, a moderately intense lowmass fragment was observed atm/z 124 (lowest mass significant fragment), and this was therefore chosen for further
CADMS/MSanalysis; see Fig. 4. Thehighestmass signal seen atm/z 921 corresponds to the eliminationof the complete sulfonatedpeptidylamido-glycan from
the peptide backbone to leave a dehydropeptide (not observed). For a full interpretation, see “Results.”
C. difficile Type B Flagellin Glycosylation
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correlation to Ser* H-3 and HMBC correlation to Ser* C-3,
indicating that -GlcNAc was linked to O-3 of a serine residue
(Ser*). Thus, the oligosaccharide 1 had the structure shown in
Fig. 5. The purified glycopeptide contained two serine residues
and one threonine residue.
Another glycopeptide fraction obtained after reseparation
contained a mixture of compounds 2 and 3 (Fig. 5). Compound
2 contained all components of the oligosaccharide 1 without an
O-Me group on O-3 of the terminal Rha and additionally a
residue of 3-amino-3,6-dideoxy--galactopyranose (Fuc3N),
acylated at the amino group with the unusual sulfopeptide. The
position of Fuc3N at O-3 of the Rha E followed from NOE and
HMBC correlations F1:E3. The glycopeptide contained three
components: taurine, alanine, and glycine. The sequence of
these components was determined based on the following
observations. Glycine C-2 was observed at its usual place
around 44 ppm, providing clear evidence that it was acylated by
the alanine moiety. In contrast, the low field position of the Ala
C-2 at 57.5 ppm indicated that itsNHgroup is alkylated, (rather
than if it was within a peptide, where the normal field position
would be 51 ppm). This provides evidence that the taurine
unit (deduced from the independent mass spectrometric anal-
ysis) is linked to the alanine and that glycine would be acylating
N-3 of Fuc3N, supporting the interpretation of the mass spec-
trometric data. The sequence of the sulfopeptide would then be
taurinyl-Ala-Gly, as indicated in Fig. 5 (compound 2).
FIGURE4.Thenegative ionnanosprayCADMS/MSspectrumofm/z124producedvia conevoltage induced in-source fragmentationofm/z9962.The
base peak (main signal) observed is present at m/z 79.96, interpreted as SO3
. , together with minor, less informative signals. This spectrum provided the first
evidence of the presence of a sulfonic acid group in the new structure. A sample of synthetic taurine was then analyzed, showing an equivalent negative ion
spectrum with base peakm/z 79.96.
FIGURE 5. C. difficile R20291 flagellar glycan compounds. Structures of isolated compounds 1, 2, and 3 are presented. A, B, C, C, D, E, and F below the
structures indicate the assignment of resonances presented in Fig. 6 and Tables 2 and 3. 381, fragment identified by MS analysis in Fig. 1 (inset,m/z 382).
TABLE 2
NMR data for compound 1
NAc: 175.8; 2.11/23.7 ppm. Me: 3.44/57.2; 3.45/57.7 ppm.
Fraction 21 H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6
RhaMe A 5.08 3.97 3.56 3.50 4.02 1.25
100.9 76.8 80.4 72.2 70.2 17.6
RhaMe B 4.89 4.27 3.45 3.46 3.75 1.29
103.5 67.0 80.5 72.2 70.1 18.2
GlcNAc C 4.67 3.87 3.60 3.54 3.49 3.79; 3.94
100.9 56.3 82.9 69.5 77.1 61.7
Ser* 4.36 4.17; 4.17
168.2 54.2 68.0
C. difficile Type B Flagellin Glycosylation
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Another component of this fraction was compound 3, which
had the same sugar structure as compound 1 but was linked to
a threonine residue. The 1H and 13C NMR data for the glyco-
peptides present in fraction 21 are shown in Tables 2 and 3, and
the HSQC spectrum is shown in Fig. 6.
These NMR data show that the R2 group in Scheme 1 of the
mass spectrometric interpretation is a methyl group (thus
allowing an alanine assignment) to give an Ala-Gly dipeptide,
with R being a hydrogen and R1 the ethyl sulfonic acid group
giving rise to taurine in the MS/MS fragmentation. The 13C
chemical shifts observed were in good agreement for an alkyl-
ated NH group in the alanine unit and with the shifts reported
for taurine. The glycan portion of the structure, assigned mass
spectrometrically as an amino-dideoxyHex-deoxyHex-methyl-
deoxyHex-HexNAc unit in Fig. 1 was then further assigned
from the NMR data as -Fuc3N-(133)--Rha-(132)-
-Rha3OMe-(133)--GlcNAc-(13)Ser. The overall struc-
ture of the “991” peptidyl-glycan is shown as compound2 in Fig.
5, and our mass spectrometric data suggest that the corre-
sponding “9982” peptidyl-glycan will have either alanine or
N-methyl glycine replacing the glycine in the dipeptide portion
of that structure, producing the observed 14-mass unit shift.
Although the NMR spectra of compounds 2 and 3 contained
additionally a minor methyl group signal, at 3.21/55.1 ppm,
which may be responsible for the observed mass increase of 14
atomic mass units in the mass spectrum of some glycopeptides
(“998”), we were unable to assign the position of this methyl
group within the structure.
Discussion
Glycosylation is a keymodification of proteins and lipids that
is often important in intermolecular and intercellular interac-
tions. Bacterial protein glycosylation systems have come under
enhanced scrutiny because of the increasing association with
pathogenic species. Recent research is providing compelling
evidence for protein glycosylation being central to the survival
and pathogenesis of many bacteria. They have been described
variously as being important in adhesion, motility, DNA
uptake, biofilm formation, autoaggregation, invasion, serum
resistance, immune evasion, and animal colonization (1–7,
19–25). Recently, the structure and biological role of flagellar
glycosylation in the enteric opportunistic pathogen C. difficile
FIGURE6.Part of the 1H-13CHSQCspectrumof themixtureof compounds2and3. The signalmarked #probably belongs to a structure 2with an additional
Megroup, not yet localized. Amino acidsmarkedwith superscript numbers are from the peptide part, sequence not determined. Thr* and Ser* are glycosylated.
TABLE 3
NMR data for compounds 2 and 3
Atomnumbering inHSO3CH2CH2NH-Ala (X) fromAla side. NAc: 175.8; 2.11/23.7
ppm. Me: 3.44/57.2; 3.45/57.7 ppm.
Fraction 21 H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6
RhaMe A 5.08 3.97 3.56 3.51 4.01 1.25
101.0 77.1 80.4 72.2 70.3 17.6
Rha E 4.89 4.21 3.80 3.58 3.80 1.32
103.2 68.2 76.9 71.4 70.2 18.3
GlcNAc C 4.66 3.87 3.60 3.54 3.48 3.77; 3.94
100.9 56.3 83.0 69.5 77.1 61.8
Fuc3NR F 5.09 3.88 4.31 3.78 4.42
96.6 67.1 52.4 71.6 68.0
Ser* 4.36 4.17; 4.17
54.2 68.0
Ala 171.5 4.20 1.61
57.5 16.5
Gly 4.06
43.7
X 3.47; 3.51 3.32; 3.32
42.9 47.7
RhaMe B 4.89 4.27 3.45 3.46 3.74 1.29
103.2 67.0 80.5 72.2 70.1 18.2
RhaMe D 5.09 3.99 3.56 3.51 4.01 1.25
100.9 76.5 80.4 72.2 70.3 17.6
GlcNAc C 4.62 3.79 3.60 3.50 3.45 3.75; 3.92
100.2 56.8 83.0 69.7 77.0 62.0
Thr* 4.53 4.32
59.3 75.9
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630 has been described (8, 9). Moreover, investigations into the
biological role of flagellar glycosylation in the emerging hyper-
virulent C. difficile RT027 and RT023 have been undertaken
and reported in our accompanying paper (26). In both C. diffi-
cile studies, flagella post-translational modification plays a role
inmotility, aggregation, and adhesion to abiotic surfaces. In the
case of C. difficile RT027, flagella glycosylation is also involved
in Caco-2 cell adhesion. In the present study, we have revealed
the discovery of a unique flagellar non-reducing end peptidyl-
amido-glycan structure on glycoproteins isolated from RT027
and other RTs (RT023, RT001, and RT106).
Following themass spectrometric discovery of unusual post-
translational modifications (PTMs) in the LC-MS and MS/MS
data from tryptic digests of the FliC protein using an instru-
ment tuned for optimal automated information-dependent
acquisition, a full battery of advanced MS techniques (15–18)
was first applied to characterize the novel components to the
extent possible on the small quantities of protein available.
These included the production of on-line high resolution
MS/MS data using a 40,000 resolving power Q-TOF geometry
instrument (see “Experimental Procedures”), allowing the
assignment of probable atomic compositions of all fragment
ions, including those clearly not derived fromnormal glycopep-
tides or previously reported PTMs. These experiments showed
for the first time the presence of sulfur-containing moieties,
and subsequent MS2 and MS3 data generated by the high sen-
sitivity andmass accuracy of the XevoQ-TOF geometry instru-
ment (15, 16) in both positive and negative ion mode allowed
the discovery of a taurine (aminoethyl-sulfonic acid) unit in the
breakdown fragments of several of the precursor ion species
investigated. Combining all of these data sets, together with
confirmatory experiments, such as hydrogen/deuterium
exchange analysis (not shown), allowed the novel structural
unit containing the sulfonic acid group to be defined as shown
in Scheme 1 (with composition C4H10NO3S). When it then
becamepossible to isolate a sufficient amount of the des-methyl
(9912) variant of the structure, a detailedNMR studywas used
to reveal the identity of the R, R1, and R2 groups shown to give
the overall PTM structure in Fig. 5. Our mass spectrometric
studies on hypervirulent strains ribotype 027, 023, 106, and 001
have shown the presence of one of these structures (9912 or
9982) and related variants (data not shown) in each of the
strains studied. The work reported here has concentrated on
what was found to be the most abundant LLDGSSTEIR tryptic
glycopeptide, but preliminary mass spectrometric analysis
shows that similar modifications are present on at least two
other flagellin peptides, QMVSSLDVALK and VALVNTS-
SIMSK. Only minor amounts of the respective free (non-glyco-
sylated) peptides were found in the digests.
In contrast to this very complex glycosylation of the flagella
of C. difficile RT027, the 630 type strain is modified with single
GlcNAc residues that are substituted with an N-methylated
threonine linked via a phosphodiester bond (8, 9). Despite the
substantial differences in glycosylation, a common feature is
the presence of a negatively charged functionality in the periph-
ery of the post-translationalmodification, namely a sulfonate in
the hypervirulent strains and a phosphoester in the 630 strain.
These charged groups are likely to be involved in ionic interac-
tions between the flagella and extracellular structures. This
could explain the phenotype of C. difficile flagellar glycosyla-
tion knockouts, where autoaggregation, biofilm formation, and
adhesion to Caco-2 cells are reduced (9, 26).
An increasing number of reports on flagellar glycosylation on
Gram-positive and Gram-negative bacterial pathogens have
been published (10, 27). In comparison with Gram-negative
bacteria, the reports on flagellar glycosylation on Gram-posi-
tive are limited. Among Gram-positive bacteria, Clostridium
spp. are the most characterized (8, 9, 28–30). There are two
other genera of Gram-positive pathogens with O-glycosylated
flagella: Listeria and Paenibacilla. Listeria monocytogenes is
glycosylated at up to six sites per monomer with a single -O-
linkedGlcNAc residue (11).Paenibacillahas a flagellamodified
with an O-linked trisaccharide composed of one hexose and
two N-acetyl-hexosamine residues at three sites of glycosyla-
tion (13). In the case of Gram-negative bacteria, the diversity of
flagellar glycosylation moieties is remarkable. Flagellins of
many Gram-negative bacterial pathogens have a single pseu-
daminic or legionaminic acid residue at each of their O-glyco-
sylation sites (10). Both of these sugars exhibit considerable
diversity due to differences in acyl functionalities. Notably,
some are acylated with amino acids. Thus, glycine andN-acetyl
glutamine have each been observed as ester-linked substituents
of pseudaminic acid in the flagella of Aeromonas caviae and
Campylobacter jejuni, respectively (31). However, there are no
reports of peptidyl substituents on glycans fromGram-negative
organisms. In addition, amino acid substituents have not pre-
viously been observed on the glycans of Gram-positive patho-
gens. Therefore, our discovery that the C. difficile RT027 fla-
gella are modified by a peptidylamido-sugar moiety is a
unique finding within both Gram-positive and Gram-nega-
tive bacteria.
Another structural component, identified in the present
study as a taurine-like non-reducing end unit, is unique in fla-
gella glycosylation from bacteria. This unit might be used by
RT027 strains as a strategy to evade the host immune system
because taurine is reported to have a key role in the regulation
of the innate immune response (32).
In some bacterial pathogens, such as the enteric pathogen
C. jejuni, glycosyltransferases and glycan biosynthetic genes are
situated adjacent to biosynthetic flagellar genes (33). ForC. dif-
ficile type B flagellin, it appears that rhamnose biosynthetic
genes (CDR20291_0223–0226), which are similar to rmlD,
rmlA, rmlC, and rmlB, lie upstream of fliC and are probably
involved in the biosynthesis of the rhamnose moieties modify-
ing the C. difficile RT027 flagella (26). Within the locus imme-
diately downstream of fliC in addition to the three putative
flagellar glycosyltransferase genes, there are a number of bio-
synthetic genes (CDR20291_0244–0247) that appear to be
responsible for synthesis of the novel terminal moiety (26).
These biosynthetic genes are present in the genomes of both
RT027 and RT023 strains. The amino acid similarity of
CDR20291_0247 to FdtB from A. thermoaerophilus suggests
that this gene product is probably involved in the production of
the 3-amino-3,6-dideoxy--galactopyranose (Fuc3N) mono-
saccharide. Previous work using Aneurinibacillus thermoaero-
philus andXamthomonas campestris enzymes have shown that
C. difficile Type B Flagellin Glycosylation
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RmlA and RmlB catalyze the first two steps for Fuc3N biosyn-
thesis (34) by producing the substrate dTDP-6-deoxy-D-xylo-
hex-4-ulose. Optimally, this substrate would be converted to
dTDP-6-deoxy-D-xylohex-3-ulose by FdtA; however, it has
been demonstrated that incubation of the 4-keto product with
FdtB and cofactors will yield a moderate level of conversion to
dTDP-Fucp3N in the absence of FdtA isomerase (34). It has
been suggested that this may be due to production of 3-keto
substrate via non-enzymatic processes (35). Because no homo-
log of FdtA appears to be present in the C. difficile R20291 type
B post-translationalmodification locus, it appears that thismay
be the mechanism whereby limited amounts of Fuc3N can be
produced in C. difficile and incorporated into the flagellar gly-
can. The heterogeneity observed in flagellin glycan composi-
tion (sulfonated peptidylamido-glycan structure and truncated
methylated trisaccharide (Rha-Rha-GlcNAc) structure) might
be explained by the inefficient production of Fuc3N from
dTDP-6-deoxy-D-xylohexose-4-ulose by FdtB. Limiting amounts
of Fuc3Nwould prevent the synthesis of the full flagellar glycan.
In addition to the FdtB homolog, there exists a putative acyl-
transferase (CDR20291_0244), which is a candidate for acylat-
ing the amino group of the fucosamine moiety. Downstream of
CDR20291_0244 lie CDR20291_0245 and CDR20291_0246,
which are co-transcribed with the glycosyltransferase genes
and encode a putative D-alanine ligase and alanine dehydroge-
nase, respectively. These genes are probably involved in the
biosynthesis of the peptidyl moiety of this novel flagellar glycan
(26).
This study reveals a unique flagellar glycosylation structure
in the bacterial pathogen C. difficile hypervirulent RT027
strains, which could provide the organismwith a novel strategy
to escape the immune system and be more virulent. Further-
more, this work highlights the diversity of glycans modifying
flagella in other hypervirulent C. difficile RTs, such as RT023,
RT001, and RT106, which could suggest different strategies of
C. difficile to evade the immune system.
Experimental Procedures
Bacterial Growth and Cultures—C. difficile strains used in
this study are shown inTable 4. Strainswere routinely grownon
Brazier’s CCEY agar (BioConnection, Leeds, UK) containing
4% (w/v) egg yolk, 250 mg/ml cycloserine, 8 mg/ml cefoxitin
(Bioconnections), and 1% defibrinated horse blood (TCS Bio-
sciences, Buckingham, UK), in blood agar (Oxoid, Hampshire,
UK) and in BHI (brain heart infusion medium (Oxoid)) and
BHIS (BHI supplementedwith 0.5% (w/v) yeast (Sigma,Gilling-
ham, UK), 0.1% L-cysteine (Sigma)) broth or agar. All cultures
were incubated at 37 °C overnight in a Don Whitney MG500
anaerobic work station (DonWhitney Scientific Ltd.).
Protein Isolation and Digestion—Bacteria were grown on
BHIS overnight, at 37 °C. C. difficile strains were harvested,
washed in phosphate-buffered saline, and resuspended in a
1:100 volume of low pH glycine (0.2 M glycine-HCl, pH 2.2) and
incubated at room temperature for 30 min with gentle shaking.
The cells were removed by centrifugation at 4 °C, and the
supernatant was neutralized with the addition of 2 M Tris to a
pH of 7–8. Flagellin preparations were analyzed by 12% SDS-
PAGE Novex NuPAGE Tris-glycine SDS-PAGE. The sepa-
rated proteins were stained with Coomassie Blue in accordance
with standard techniques. Flagellin bands were excised, lyoph-
ilized, and digested with trypsin (EC 3.4.21.4; Promega) over-
night. Peptides were extracted from gel pieces and studied by
LC-MS/MS analysis.
Mass Spectrometry—Positive ion Q-TOF technology (15, 16)
was used to study the tryptic digests of proteins isolated from
the various strains of C. difficile ribotypes in LC-MS and
MS/MS experiments conducted on several instruments. A
Sciex QStar Pulsar 1 instrument with LC Packings nano-LC
using a C-18 nanocapillary (75 m 15-cm Pepmap) column
eluting with a 0.05% formic acid, 5–95% acetonitrile gradient
over 90 min, and information-dependent acquisition was used
for the low resolution (5000 resolving power) analysis of digest
mixtures. A Waters XevoG2 instrument with Acquity micro-
bore UPLC, using a C-18 (1  50-mm BEH) column eluting
with a 0.1% formic acid, 0–85% acetonitrile gradient over 40
min, with data-dependent acquisition, was used for detailed
positive and negative ionMSn and cold isotope-labeling exper-
iments, and a Waters Synapt G2-S, with nanoAcquity UPLC
and a 75 m  15-cm BEH column and gradient elution with
0.05% formic acid, 5–95% acetonitrile over 45 min, and data-
dependent acquisition, was used for the collection of the high
resolution (40,000 resolving power) MS/MS data from which
atomic compositions could be calculated. MS3 data were gen-
erated on the XevoG2 instrument on various fragment ions of
interest by nanospray of 1–2l of LC-collected fractions loaded
into borosilicate needles, using high cone voltage to achieve
source fragmentation and then passing the fragment ions of
interest into the collision cell for CADMS/MS.
Negative ion mass spectrometry was used to study collected
fractions of interest. These were adjusted to basic pH using 10%
ammonia, and then MS3 data were generated on the XevoG2
instrument on various fragment ions of interest by nanospray as
described above.
TABLE 4
C. difficile strains used in this study
Strains Characteristics Source
R20291 PCR ribotype 027, isolated from an outbreak in 2004–2005 Aylesbury, UK
CD196 Ribotype 027, isolated from a pseudomembranous colitis case France, 1985
BI-16 PCR ribotype 027, isolated from an outbreak in 2004 Augusta, GA
CD305 PCR ribotype 023, isolated from an outbreak in 2011 Barts Hospital, UK
CD1426 PCR ribotype 023, isolated from an outbreak in 2010 Queens Hospital Remford, UK
CD1714 PCR ribotype 023, isolated from an outbreak in 2011 Whipp’s Cross Hospital, UK
106-01 PCR ribotype 106, isolated from an outbreak in 2008 Fatal case, Glasgow, UK
001-01 PCR ribotype 001, isolated from an outbreak in 2008 Paisley, UK
001-07 PCR ribotype 001, isolated from an outbreak in 2008 Edinburgh, UK
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NMRGlycan Structural Analysis—Large scale preparation of
flagellin was performed by growing C. difficile R20291 over-
night on 40 BHIS agar plates at 37 °C in an anaerobic chamber.
Cells were harvested into sterile distilled water (dH2O), and
cells were vortexed for 3 min to release flagella filaments
from cells. Bacterial cells were removed by centrifugation at
13,000 rpm in an Eppendorf centrifuge for 5 min (twice). The
supernatant was collected, pooled, and passed through a
13-mm PVDF filter. This sterile supernatant was then centri-
fuged at 55,000 rpm for 1 h at 4 °C in a Beckman Optima TLX
Ultracentrifuge using a BeckmanTLA 120.2 rotor. The pelleted
material was resuspended in dH2O, and the ultracentrifugation
step was repeated. The supernatant was discarded, and the pel-
let was resuspended in dH2O. Flagellin protein was obtained
frommultiple bacterial growths (10) to give a total of 10mg of
flagellin protein at a concentration of 0.4mg/ml (as determined
by the Bio-Rad protein assay). To obtain glycanmaterial devoid
of protein backbone for structural analysis, flagellin (10mg)was
digested with proteinase K at a ratio of 1:1 (Sigma) in 10 mM
Na2PO4, pH 7.6, at 37 °C for 48 h. The proteinase K-digested
material was lyophilized and resuspended in dH2O, and the
samplewas fractionated by gel filtration on aBiogel P10 column
(2.5  80 cm, 1% acetic acid, refractive index detector). Each
fraction was analyzed by 1H NMR, and the glycopeptide-con-
taining fraction was then applied to a Zorbax C18 column in
a 0.1% TFA, 80% acetonitrile gradient with a UV detector at
220 nm, and fractions were collected and reexamined by 1H
NMR for the presence of glycan. Separation was then
repeated with selected fractions using a gradient from 4 to
20% of 80% acetonitrile over 1 h. All fractions were then
analyzed by NMR.
NMRSpectroscopy—NMRexperiments were carried out on a
Bruker AVANCE III 600 MHz (1H) spectrometer with a 5-mm
Z-gradient probe with acetone internal reference (2.225 ppm
for 1H and 31.45 ppm for 13C) using standard pulse sequences
cosygpprqf (gCOSY), mlevphpr (TOCSY, mixing time 120ms),
roesyphpr (ROESY, mixing time 500 ms), hsqcedetgp (HSQC),
hsqcetgpml (HSQC-TOCSY, 80-ms TOCSY delay), and hmb-
cgplpndqf (HMBC, 100-ms long range transfer delay). Resolu-
tion was kept	3 Hz/point in F2 in proton-proton correlations
and 	5 Hz/point in F2 of H-C correlations. The spectra were
processed and analyzed using the Bruker Topspin version 2.1
program.
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